Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE)

Overview of attention for article published in BMC Urology, November 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 40 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 30,430 followers.

RT @AndreaNecchi: Just published our article "Health-related quality of life in the randomize.." with #BMC https://t.co/nNjOfOMgUs # via @…

Reply Repost Favourite

👏🏻👏🏻👏🏻

Reply Repost Favourite

Just published our article "Health-related quality of life in the randomize.." with #BMC https://t.co/nNjOfOMgUs # via @ BioMedCentral

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.